Main Session
Sep
29
SS 36 - Predicting Benefit and Toxicity: Biomarkers in Prostate Radiotherapy
316 - Interpreting the Model: Biologic Pathways Underlying a Clinically Validated Multimodal Digital Pathology AI Biomarker in Metastatic Prostate Cancer
Presenter(s)
Philip Sutera, MD - University of Rochester Medical Center, Rochester, NY